Abstract
We discuss here the rapid progress of stem cell therapy in myocardial infarction. In particular, we focus on the issue of transdifferentiation as a "hallmark" of the stem cell's potential to replace damaged cells of the heart. A study by Henning and colleagues in this issue of Cell Transplantation supports the alternative notion of a nontransdifferentiation- mediated protection of the heart as an equally robust mechanism underlying the therapeutic potential of stem cells.
Original language | English (US) |
---|---|
Pages (from-to) | 725-727 |
Number of pages | 3 |
Journal | Cell Transplantation |
Volume | 13 |
Issue number | 7-8 |
DOIs | |
State | Published - Jan 1 2004 |
Keywords
- Myocardial infarction
- Stem cell therapy
- Therapeutic potential
- Transdifferentiation
ASJC Scopus subject areas
- Biomedical Engineering
- Cell Biology
- Transplantation